Search Results for 'creagh medical'
-
Cardiovascular
Surmodics Enrolls First Patient in TRANSCEND Pivotal Clinical Trial for SurVeil Drug-Coated Balloon
Plan to enroll up to 446 patients at approximately 78 sites.Business Wire 11.06.17
-
Surmodics Announces Global Approvals of .014-Inch Low-Profile PTA Balloon Dilation Catheter
The product received FDA 510(k) and CE Mark clearances.Business Wire 10.02.17
-
Cardiovascular
Surmodics Receives IDE Approval to Initiate Pivotal Trial of the SurVeil Drug-Coated Balloon
SurVeil DCB design includes new proprietary coating for interventional treatment of PAD.Business Wire 08.09.17
-
Surmodics Appoints Medtech Veteran to its Board of Directors
Newest member is currently the chief operating officer at Mitralign.Business Wire 04.21.17
-
Contract Manufacturing | R&D & Design
Surmodics IVD Launches Breakthrough StabilBlock Immunoassay Stabilizer
The company now offers three options to assay developers.Businesswire 08.02.16
-
Contract Manufacturing
SurModics Acquires NorMedix
Purchase furthers transformation strategy with vascular expertise and R&D capabilities.Business Wire 01.12.16
-
Contract Manufacturing
SurModics Acquires Creagh Medical
Deal accelerates the strategic transformation into a whole-product solutions provider.Surmodics Inc. 11.23.15
